SUNPHARMA's weekly performance was lackluster, with a return of -0.17% and a Sharpe Ratio of -0.02, indicating poor risk-adjusted returns. The stock's volatility was relatively high at 23.27%, and it experienced a max drawdown of -2.23%. Compared to its peers, SUNPHARMA underperformed HINDUNILVR but outperformed DRREDDY, while being significantly less volatile than DIVISLAB. Overall, the stock's performance was mediocre and moderately risky this week.

[Volatility: 23.27%]